إعلان
إعلان
BEAM
Beam Therapeutics Inc. Common Stock
27.11
USDبرعاية
-0.61
-2.19%
٠٢ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
27.20
+0.09
+0.34%
تقارير أرباح BEAM
النسبة الإيجابية المفاجئة
BEAM تفوق 14 من 24 آخر التقديرات.
58%
التقرير التالي
بيانات التقرير القادم
٢٣ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$13.29M
/-$1.16
التغير الضمني من Q3 25 (Revenue/ EPS)
+37.08%
/+5.45%
التغير الضمني من Q4 24 (Revenue/ EPS)
-55.79%
/+6.42%
Beam Therapeutics Inc. Common Stock earnings per share and revenue
On ٠٤ نوفمبر ٢٠٢٥, BEAM reported earnings of -1.10 USD per share (EPS) for Q3 25, missing the estimate of -1.06 USD, resulting in a -3.72% surprise. Revenue reached 9.70 مليون, compared to an expected 12.66 مليون, with a -23.41% difference. The market reacted with a -6.23% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 16 analysts forecast an EPS of -1.16 USD, with revenue projected to reach 13.29 مليون USD, implying an increase of 5.45% EPS, and increase of 37.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
٢٢ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.57
الفعلي
-$0.73
مفاجئة
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
١٩ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.25
الفعلي
-$0.19
مفاجئة
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
٢٣ ديسمبر ٢٠٢٥ For ربع سنوي4 25
Estimate
-$0.12
الفعلي
-$0.06
مفاجئة
+50.98%
الأسئلة الشائعة
What were Beam Therapeutics Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Beam Therapeutics Inc. Common Stock reported EPS of -$1.10, missing estimates by -3.72%, and revenue of $9.70M, -23.41% below expectations.
How did the market react to Beam Therapeutics Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -6.23%, changed from $24.25 before the earnings release to $22.74 the day after.
When is Beam Therapeutics Inc. Common Stock expected to report next?
The next earning report is scheduled for ٢٣ فبراير ٢٠٢٦.
What are the forecasts for Beam Therapeutics Inc. Common Stock's next earnings report?
Based on 16
analysts, Beam Therapeutics Inc. Common Stock is expected to report EPS of -$1.16 and revenue of $13.29M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان